Alignment Healthcare ALHC
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Alignment Healthcare (ALHC) Business Model and Operations Summary
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
Key Insights
Alignment Healthcare (ALHC) Core Market Data and Business Metrics
Latest Closing Price
$18.08Market Cap
$3.51 BillionPrice-Earnings Ratio
-26.99Total Outstanding Shares
191.83 Million SharesTotal Employees
1,679Dividend
No dividendIPO Date
March 26, 2021SIC Description
Hospital & Medical Service PlansPrimary Exchange
NASDAQHeadquarters
1100 W. Town And Country Road, Orange, CA, 92868
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Investing Activities | $39.19 Million |
| Net Cash Flow, Continuing | $229.99 Million |
| Net Cash Flow From Investing Activities, Continuing | $39.19 Million |
| Net Cash Flow From Financing Activities | $156.03 Million |
| Net Cash Flow | $229.99 Million |
| Net Cash Flow From Operating Activities | $34.77 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Nonoperating Income/Loss | $-26.50 Million |
| Other Operating Expenses | $2.41 Billion |
| Operating Income/Loss | $-101.56 Million |
| Net Income/Loss | $-128.07 Million |
| Net Income/Loss Attributable To Noncontrolling Interest | $-36,000 |
| Diluted Earnings Per Share | $-0.67 |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss | $0 |
| Comprehensive Income/Loss Attributable To Parent | $-128.07 Million |
| Comprehensive Income/Loss | $-128.07 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Equity Attributable To Noncontrolling Interest | $1.10 Million |
| Wages | $39.93 Million |
| Noncurrent Liabilities | $329.26 Million |
| Other Current Liabilities | $311.91 Million |
| Noncurrent Assets | $120.42 Million |
| Intangible Assets | $4.55 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||